Firebrick Pharma Limited

ASX (AUD): Firebrick Pharma Limited (FRE)

Last Price

0.068

Today's Change

-0.002 (2.85%)

Day's Change

0.068 - 0.068

Trading Volume

15,000

Profile
FRE

Exchange:  Australian Securities Exchange Australian Securities Exchange

Currency:  AUD AUD

Sector:  Healthcare - Healthcare Healthcare - Healthcare

Industry: 

CEO:  Dr. Peter Laurence Molloy BSc, FAICD, MBA Dr. Peter Laurence Molloy BSc, FAICD, MBA

Full Time Employees:  0 0

IPO Date:  2022-01-27 2022-01-27

CIK: 

ISIN:  AU0000197352 AU0000197352

CUSIP: 

Beta:  1.63 1.63

Last Dividend:  0.00 0.00

Dcf Diff:  0.07 0.07

Dcf:  0.00 0.00

Description

Firebrick Pharma Limited engages in the development and commercialization of nasal spray treatment for the common cold under the Nasodine name in Australia. The company was incorporated in 2012 and is based in Melbourne, Australia.

Address

440 Collins Street,
Melbourne, VIC 3000, AU

1300 301 874

http://www.firebrickpharma.com

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment